Previous 10 | Next 10 |
Shares of Mind Medicine (NASDAQ: MNMD) , also known as MindMed, had crashed by 49.3% as of 12:08 p.m. ET Wednesday. The steep decline came after the clinical-stage biopharmaceutical company announced the pricing of its latest public offering. MindMed plans to sell 7,058,823 comm...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Sundry Photography / Shutterstock.com Taiwan Semiconductor (NYSE: TSM ) stock isn’t doing so hot Wednesday on reports that Apple (NASDAQ: AAPL ) is decreasing production for the iPhone 14. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Tero Vesalainen / Shutterstock.com Lyft (NASDAQ: LYFT ) stock is getting a boost on Wednesday after the ride-sharing company revealed a stop to hiring in the U.S. for the rest of the year. A spokespe...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips MindMed (NASDAQ: MNMD ) stock is plunging 51% today after the drug maker announced yesterday shortly before the market closed that it would sell an undisclosed number of common shares of MMED stock, along with an un...
Mind Medicine Inc. (“MindMed”) (NASDAQ: MNMD) (NEO: MMED) has priced its underwritten public offering of 7,058,823 common shares at $4.25. The shares come with warrants and the price includes both. The gross proceeds from the offering are expected to be approxima...
Mind Medicine (MindMed) ( NASDAQ: MNMD ) is down 33.01% after-hours after the firm has priced its underwritten public offering of 7,058,823 common shares, together with accompanying warrants to purchase 7,058,823 common shares at combined offering price at $4.25. ...
MindMed Announces Pricing of Public Offering of Common Shares and Warrants Canada NewsWire NEW YORK , Sept. 27, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. ("MindMed") (NASDAQ: MNMD) (NEO: MMED), a clinical stage biopharmaceutical company developing novel ...
Mind Medicine (MiniMed) ( NASDAQ: MNMD ) said it expects to offer and sell common shares along with warrants in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be comp...
MindMed Announces Proposed Public Offering of Common Shares Canada NewsWire NEW YORK , Sept. 27, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. ("MindMed") (Nasdaq: MNMD) (NEO: MMED), a clinical stage biopharmaceutical company developing novel products t...
Speaking during a House Ways and Means Committee bill markup Wednesday, Rep. Earl Blumenauer (D-Ore.) said that psychedelic drugs have "real potential" as mental health therapies with "less impact" than prescription drugs. "Oregon is involved in an experiment with therapeutic psilocyb...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
2024-07-26 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...